Ken Griffin Armata Pharmaceuticals, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 300 shares of ARMP stock, worth $735. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300Holding current value
$735% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding ARMP
# of Institutions
31Shares Held
771KCall Options Held
300Put Options Held
1K-
Vanguard Group Inc Valley Forge, PA260KShares$637,1780.0% of portfolio
-
Geode Capital Management, LLC Boston, MA106KShares$259,3000.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$245,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX44.7KShares$109,4700.0% of portfolio
-
State Street Corp Boston, MA40.3KShares$98,7350.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $88.6M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...